UK
UK
Jan-09
Jan-09
Neurology Pharmacoepidemiology
Read moreDec-08
Dec-08
Nov-08
Endocrinology Pharmacoepidemiology
Read moreNov-08
Cardiovascular Pharmacoepidemiology
Read moreNov-08
Endocrinology Healthcare Cost Pharmacoepidemiology
Read moreNov-08
Mental Health Neurology Paediatrics
Read moreNov-08
Gynecology and Obstetrics Paediatrics Pharmacoepidemiology Respiratory Women's Health
Read moreNov-08
Endocrinology Healthcare Cost Pharmacoepidemiology
Read moreNov-08
Endocrinology Healthcare Cost Pharmacoepidemiology
Read moreNov-08
Cardiovascular Pharmacoepidemiology
Read more| Date | Title | Categories | |
|---|---|---|---|
| Jan-09 | The importance of defining periods of complete mortality reporting for research using automated data from primary care | Read more | |
| Jan-09 | Use of pregabalin in patients with painful neuropathic disorders under the care of general practitioners in the U.K | Read more | |
| Dec-08 | Discontinuation Rates of Anticholinergic Medications Used for the Treatment of Lower Urinary Tract Symptoms | Read more | |
| Dec-08 | The association between idiopathic pulmonary fibrosis and vascular disease: a population-based study | Read more | |
| Nov-08 | Improved Glycaemic Control by Switching from Insulin NPH to Insulin Glargine: a Retrospective Observational Study | Read more | |
| Nov-08 | Age threshold for routine aspirin treatment to prevent cardiovascular disease in patients without diabetes | Read more | |
| Nov-08 | Cost-Utility of Insulin Glargine Compared to Pre Mix in Type 2 from Public Payer Perspective in Poland | Read more | |
| Nov-08 | Early head injury and attention deficit hyperactivity disorder: retrospective cohort study | Read more | |
| Nov-08 | Effect of maternal asthma, exacerbations and asthma medication use on congenital malformations in offspring: a UK population-based study |
Gynecology and Obstetrics Paediatrics Pharmacoepidemiology Respiratory Women's Health |
Read more |
| Nov-08 | Is Insulin Glargine a Cost Effective Option in Treatment of Patients with Type DM1 with Baseline HBA1C Above 8% in Comparison to NPH and Premix in Poland? | Read more | |
| Nov-08 | Is Insulin Glargine a Cost-Effective Option for Treatment of Patients Naive to Insulin Treatment with Type 2, Baseline HBA1C Above 8% and Age Below 65 Years in Comparison to NPH and Premix in Poland? | Read more | |
| Nov-08 | Role of dose potency in the prediction of risk of myocardial infarction associated with nonsteroidal anti-inflammatory drugs in the general population | Read more |
